CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

As healthcare spending continues to rise and regulatory pressure intensifies, companies like CVS Health CVS find themselves ...

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will ...

Adjusted earnings for 2025 will be $5.75 to $6 a share, CVS said, while the average estimate of analysts surveyed by ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...

CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...

CVS Health (CVS) stock jumps 9% after beating Q4 revenue & earnings forecasts thanks mainly to its Health Care Benefits and ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

For the quarter ended December 2024, CVS Health (CVS) reported revenue of $97.71 billion, up 4.2% over the same period last year. EPS came in at $1.19, compared to $2.12 in the year-ago quarter.

CVS Health reported Q4 revenue of $97.71B, surpassing the $97.19B consensus. 2025 revenue is expected to exceed $134B, driven by higher prescription volumes. Get real-time earnings alerts before ...